Indian Journal of Endocrine Surgery and Research

Register      Login

VOLUME 18 , ISSUE 1 ( January-June, 2023 ) > List of Articles

CASE SERIES

Tuberculosis and Malignancy: A Menacing Coexistence

Mithun Raam

Keywords : Antitubercular therapy, Chemotherapy, Malignancy, Tuberculosis

Citation Information : Raam M. Tuberculosis and Malignancy: A Menacing Coexistence. 2023; 18 (1):27-30.

DOI: 10.5005/jp-journals-10088-11209

License: CC BY-NC 4.0

Published Online: 30-06-2023

Copyright Statement:  Copyright © 2023; The Author(s).


Abstract

Introduction: Tuberculosis (TB) and malignancy are major public health problems in India. We often encounter circumstances where both these entities may coexist and pose a host of challenges in management. Case description: We report a case series of patients who were diagnosed with coexistent tuberculosis and malignancy and discuss the etiopathogenesis, its implications in concurrent chemotherapy, antitubercular therapy, and caveats for surgery in this subset of patients. Discussion: Tuberculosis in patients with malignancy may be more prevalent secondary to immunosuppression due to the malignancy or chemotherapy, local structural changes to the lung, local damage due to radiotherapy and common risk factors such as smoking, alcohol and poor nutrition. It may be prudent to screen for latent infection prior to initiation of systemic chemotherapy or targeted therapy. Conclusion: Disease burden of tuberculosis and malignancy, drug toxicity, compliance, surgery in TB patients, and infection prevention have to be considered to formulate a guideline for management of these patients. Clinical significance: This case series discusses a practical approach to the common scenario where the two important public health problems of tuberculosis and malignancy coexist.


HTML PDF Share
  1. Global Tuberculosis Report 2021 [cited March 31, 2023]. Available from: https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2021.
  2. India TB Report 2022: Central TB Division [cited March 31, 2023]. Available from: https://tbcindia.gov.in/index1.php?lang=1&level=1&sublinkid=5613&lid=3658.
  3. Noncommunicable Diseases [cited March 31, 2023]. Available from: https://www.who.int/india/health-topics/noncommunicable-diseases.
  4. Cancer Today [cited March 31, 2023]. Available from: http://gco.iarc.fr/today/home.
  5. Vishwakarma D, Bhoi SR, Rannaware A, et al. Latent tuberculosis in India: An overview. Cureus 2023;15(3).e35706. DOI: 10.7759/cureus.35706.
  6. Menzies D, Al Jahdali H, Al Otaibi B. Recent developments in treatment of latent tuberculosis infection. Indian J Med Res 2011;133(3):257–266. PMCID: PMC3103149.
  7. Shu C-C, Liao K-M, Chen Y-C, et al. The burdens of tuberculosis on patients with malignancy: Incidence, mortality and relapse. Sci Rep 2019;9(1):11901. DOI: 10.1038/s41598-019-48395-8.
  8. Jackson T, Thomas J. Tuberculosis: The implications for anaesthesia. South Afr J Anaesth Analg 2013;19(6):301–305. DOI: 10.1080/22201173.2013.10872945.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.